Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ML.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used